When three lines of human cancer cells (SH-SY5Y neuroblastoma, U937 histolytic cells, breast cancer cells) were incubated with 1-10 nanomolar GHK, the programmed cell death system (apoptosis) was reactivated and cell growth inhibited, suggesting the peptide can restore normal growth control mechanisms in dysregulated cells

Key Points: GI symptoms are the most common adverse effects, ranging from expected nausea and vomiting to gastroparesis and, rarely, functional obstruction Delayed gastric emptying has important airway implications and a cautious approach to airway management is warranted Biliary disease is one of the most clinically significant complications, particularly early in treatment and with rapid weight loss Pancreatitis is rare, and current evidence does not support a strong causal relationship EDKA and AKI are uncommon but important to recognize in the right context Conclusions: GLP-1 receptor agonists have transformed the management of diabetes and obesity, with clear benefits in weight loss, glycemic control, and cardiovascular outcomes
A single random GH measurement often provides limited information because you might have the blood drawn between pulses when levels are naturally low
Medications like Ozempic, Wegovy, Zepbound and Saxenda have blown up in popularity since the 2020 pandemic
2012, 7 (3): e33739-10.1371/journal.pone.0033739
Changes in mental health GLP-1s and other incretin medications can have a range of effects on a persons mental and emotional well-being